Replies to post #5034 on Amarin Corp Plc (AMRN)

[Rawnoc]

Lovaza didn't take off until GSK got its paws on it. Had nothing to do with a launch cycle as implied.

AMRN will miss estimates badly with the Q1 report. Staying put and taking it is not a savvy investment strategy.